Achillion Pharma CVR
13F holders, Q2 2024 (June 30)1holders −1
0new positions
1sold out
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Achillion Pharma CVR in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holder was Rhumbline Advisers ($0).
- Company
- Achillion Pharma CVR
- CUSIP
- 004CVR031
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $3K |
All 13F filers, Q1 2024 → Q2 2024: 7,220 shares sold, net −7,220 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Reduce -1.8% | 52,365 | $0 |
"% of holder's portfolio" is ACHILLION PHARMA CVR's weight in each manager's 13F, not the share of Achillion Pharma CVR the manager owns.